SecBot SecBot
SC TO-T/A ·Filed Nov 12, 2026

PCRX

Pacira BioSciences, Inc.
MIXED
Impact 7/10
Horizondays Processed4d 10h ago SEC0001140361-26-043435
Notable filing: SC TO-T/A
Actionable Insight ◆ Mixed

The disclosure lawsuits are routine in M&A and unlikely to block the deal given the board's recommendation and the absence of a financing condition. Monitor for any preliminary injunction ruling before the November 16 expiration.

DirectionMixed
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$36.46
T+0 close · Nov 12, 2026 · via day close
Latest settled
+0.05%
T+1 · $36.48
Vs SPY
+1.97%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $36.46entry
  2. T+1 · 20h ago +0.05%α +1.97% · $36.48
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

Executive Summary

Viatris and its wholly owned subsidiary Peach Purchaser Sub Inc. filed Amendment No. 1 to their Schedule TO, updating the litigation section to disclose two stockholder lawsuits and fifteen demand letters challenging the adequacy of disclosures in the $36.50 per share cash tender offer for Pacira BioSciences. The Pacira defendants intend to vigorously defend the actions, and the offer terms remain unchanged.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Two stockholder complaints filed in New York Supreme Court alleging omitted/misrepresented information in Schedule 14D-9.
  • Fifteen demand letters (including two draft complaints) received by Pacira seeking additional disclosures.
  • Offer price remains $36.50 per share in cash, unchanged.
  • Pacira defendants intend to vigorously defend the actions.
  • Tender offer expires November 16, 2026; expected close on or around November 17, 2026 per prior filings.

Financial Impact

No financial impact stated; litigation seeks injunctive relief and rescission but no damages quantified.

Risk Factors

  • A court could grant preliminary injunctive relief delaying the tender offer or merger.
  • Additional shareholder lawsuits or demand letters may be filed.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC TO-T/A Filing (Primary)0001140361-26-043435
Document: 0001140361-26-043435-index-headers.html0001140361-26-043435
Document: 0001140361-26-043435-index.html0001140361-26-043435
Document: 0001140361-26-043435.txt0001140361-26-043435

Track record

29 reports on PCRX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +42.26% at T+60 after the Aug 6, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Bearish 6/10 Entry $36.46 Now $36.48 −0.05% settles Dec 14
  2. Nov 12, 20264d ago SC TO-T/A Mixed 7/10 Viewing Entry $36.46 Now $36.48 +0.05% settles Dec 14
  3. Nov 12, 20264d ago SC 14D-9/A Neutral 3/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
  4. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $36.43 Now $36.48 +0.14% settles Dec 7
  5. Nov 3, 202613d ago SC 14D-9/A Neutral 3/10 Entry $36.40 Now $36.48 +0.22% settles Dec 3
  6. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
  7. Oct 30, 202617d ago SC 14D-9 Bullish 7/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
  8. Oct 30, 202617d ago SC TO-T Mixed 7/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
  9. Oct 13, 20264w ago SC 13D/A Bearish 7/10 Entry $36.40 to $36.46 Now $36.48 −0.22% ▼ −0.16% −1.44% vs SPY
  10. Oct 8, 20265w ago SC TO-C Bullish 7/10 Entry $36.31 to $36.43 Now $36.48 +0.47% ▲ +0.33% +5.89% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 6h 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026